The Evidence Multiple large cardiovascular outcome trials have demonstrated GLP-1 medications reduce heart attacks, strokes, and cardiovascular death: SUSTAIN-6 (semaglutide): 26% reduction in major adverse cardiovascular events (MACE) in patients with Type 2 diabetes and high cardiovascular risk
DEET N , N -Diethyl- meta -toluamide, also called diethyltoluamide or DEET (/dit/, from DET, the initials of di- + ethyl + toluamide), [1] [2] is the oldest active ingredient, and one of the most effective and common, in commercial insect repellents
Retrieved 18 January 2014
[6] Muttenthaler M, et al
It has completed Phase 3 clinical trials (the REDEFINE program) with positive results, and Novo Nordisk is expected to seek FDA approval
For those interested in diving deeper into the science behind these compounds, we've included our research library below where you can explore the available literature and learn more about each product